-+ 0.00%
-+ 0.00%
-+ 0.00%

HVIVO Acquires German Research Institute CRS Clinical Research

MT Newswires·08/27/2026 02:45:11
Listen to the news
02:45 AM EDT, 08/27/2026 (MT Newswires) -- HVIVO (HVO.L) acquired Germany-based clinical research institute CRS Clinical Research Services Berlin, according to a Thursday filing. The clinical development company paid 25,000 euros as upfront consideration. The deal also includes an earnout payment, which will be 18% of CRS Clinical Research's annual revenue for the next three years. HVIVO expects the acquisition to be immediately accretive to its earnings.